Toward the harmonization of immune monitoring in clinical trials: quo vadis?

Affiliations

Comment

C M Britten et al. Cancer Immunol Immunother. 2008 Mar.

. 2008 Mar;57(3):285-8.

doi: 10.1007/s00262-007-0379-z. Epub 2007 Aug 25.

¹ Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands. cebritten@web.de

No abstract available

Comment on

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).
Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Kast WM, Hoos A; Elispot Proficiency Panel of the CVC Immune Assay Working Group. Janetzki S, et al. Cancer Immunol Immunother. 2008 Mar;57(3):303-15. doi: 10.1007/s00262-007-0380-6. Epub 2007 Aug 25. Cancer Immunol Immunother. 2008. PMID: 17721781 Free PMC article.
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.
Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C, Mander A, Walter S, Paschen A, Müller-Berghaus J, Haas I, Mackensen A, Køllgaard T, thor Straten P, Schmitt M, Giannopoulos K, Maier R, Veelken H, Bertinetti C, Konur A, Huber C, Stevanović S, Wölfel T, van der Burg SH. Britten CM, et al. Cancer Immunol Immunother. 2008 Mar;57(3):289-302. doi: 10.1007/s00262-007-0378-0. Epub 2007 Aug 25. Cancer Immunol Immunother. 2008. PMID: 17721783 Free PMC article.

1. Romero P, Cerottini JC, Speiser DE. Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination. Cancer Immunol Immunother. 2004;53:249. doi: 10.1007/s00262-003-0473-9. - DOI - PMC - PubMed
1. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med. 2004;10:909. doi: 10.1038/nm1100. - DOI - PMC - PubMed
1. Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G. Cancer vaccine clinical trial working groupA clinical development paradigm for cancer vaccines and related biologics. J Immunother. 2007;30:1. doi: 10.1097/01.cji.0000211341.88835.ae. - DOI - PubMed
1. Cox JH, Ferrari G, Kalams SA, Lopaczynski W, Oden N, D’Souza MP. Elispot collaborative study group results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Res Hum Retroviruses. 2005;21:68. doi: 10.1089/aid.2005.21.68. - DOI - PubMed
1. Janetzki S, Cox JH, Oden N, Ferrari G. Standardization and validation issues of the ELISPOT assay. Methods Mol Biol. 2005;302:51. - PubMed